---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-021504"
form_type: "8-K"
ticker: "PMI"
cik: "0002030617"
company_name: "Picard Medical, Inc."
filed_at: "2026-06-24T11:45:56+00:00"
generated_at: "2026-06-24T11:50:10.999583+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Picard Medical CEO Patrick Schnegelsberg steps down; Chairman Richard Fang named interim CEO

## Summary
- Patrick NJ Schnegelsberg resigned as CEO and board member effective June 18, 2026; departure not related to any disagreement.
- Board appointed Richard Fang, Ph.D., current Chairman, as Interim CEO effective June 18, 2026; he will serve until permanent successor found.
- Dr. Fang previously served as CEO from 2021 to 2023; founded Reach Surgical and has over 20 years med-tech experience.
- As Interim CEO, Dr. Fang will receive an annual salary of $400,000.

## SEC filing metadata
- accession: 0001437749-26-021504
- form_type: 8-K
- ticker: PMI
- cik: 0002030617
- company_name: Picard Medical, Inc.
- filed_at: 2026-06-24T11:45:56+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2030617/000143774926021504/0001437749-26-021504-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2030617/000143774926021504/pmi20260618_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-021504
- JSON: https://secwatch.observer/filing/0001437749-26-021504.json
- Plain text: https://secwatch.observer/filing/0001437749-26-021504.txt

## Key facts
- Executive change
  Richard Fang was appointed as Interim Chief Executive Officer at Picard Medical, Inc..
  - Action: appointed
  - Role: Interim Chief Executive Officer
  source text: The Board appointed Richard Fang, Ph.D., 60, as the Company's Interim Chief Executive Officer, effective as of the Separation Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/2030617/000143774926021504/0001437749-26-021504-index.htm
- Executive change
  Patrick NJ Schnegelsberg resigned as Chief Executive Officer and Director at Picard Medical, Inc..
  - Action: resigned
  - Role: Chief Executive Officer and Director
  source text: On June 17, 2026, Patrick NJ Schnegelsberg notified Picard Medical, Inc. (the "Company") of his decision to step down as Chief Executive Officer and as a member of the Board of Directors of the Company (the "Board"), effective June 18, 2026
  evidence_url: https://www.sec.gov/Archives/edgar/data/2030617/000143774926021504/0001437749-26-021504-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.